Case details

Print
Merger control
Case reference
Ccent/2025/89 - Alcon / STAAR
Acquiring
Alcon Inc.
Description
It is a global pharmaceutical company, headquartered in Geneva, Switzerland, dedicated to the research, development, production, distribution, and marketing of eye care products in two business areas: (i) surgical products, for example, cataract, retinal, and refractive surgeries; and (ii) vision care products, such as, but not limited to, disposable contact lenses and lens care products. In Portugal, it operates through its subsidiary Alcon Portugal – Produtos e Equipamentos Oftalmológicos, Lda.
Acquired
STAAR Surgical Company
Description
It is a US company, headquartered in California, whose activity in Portugal and globally consists of the production and sale of phakic lenses, used in the correction of refractive errors. In Portugal, it markets EVO and EVO+ lenses for myopia, as well as Visian ICL lenses for hyperopia and EVO Viva ICL lenses for myopia combined with presbyopia, also supplying the injection system necessary for intraocular lens implantation.
Sector
Activity (NACE)
Applicable legislation
Notification thresholds
Type of merger
Cooperation with sector regulators
Status
Ongoing
Type of Investigation
AdC’s decision
Case description

The merger transaction consists of Alcon Inc.'s ("Alcon") acquisition of sole control of STAAR Surgical Company ("STAAR") through its indirect subsidiary Rascasse Merger Sub, Inc..

Timeline
Click here to see your activities